john's wort glutathione St. Wort: Usefulness and Safety Mechanisms of hepatocellular toxicity associated
Description
These services cannot be reported separately when performed at the same operative session
o In September 2025, Rybelsus (oral semaglutide) received an EU label update based on the SOUL trial, making it the first and only oral GLP-1 RA with proven cardiovascular benefits, having demonstrated a 14% reduction in cardiovascular death, heart attack, and stroke in high-risk type 2 diabetes patients
Therefore, developing novel otoprotective methods against drug-induced ototoxicity is crucial and urgent
Toxicology 2005;214:3956
